Table of Contents
ISRN Endocrinology
Volume 2011, Article ID 803948, 8 pages
http://dx.doi.org/10.5402/2011/803948
Research Article

Patient Acceptance, Ease of Use, and Preference for Norditropin NordiFlex with NordiFlex PenMate: Results from an Open-Label, User Survey of Everyday Use

1Department of Paediatrics, Division of Endocrinology, Sophia Children’s Hospital/Erasmus University Medical Centre, 3015 GJ Rotterdam, The Netherlands
2Kinderzentrum am Johannis Platz, 04103 Leipzig, Germany
3Biopharm Medical Affairs, Novo Nordisk Health Care AG, Andreasstrasse 15, Oerlikon 8050, Zurich, Switzerland
4Clinical Research Department, Novo Nordisk Pharma GmbH, 55127 Mainz, Germany
5Goteborg Pediatric Growth Research Center, Institute for Clinical Sciences, Sahlgrenska Academy at Goteborg University, SE41345 Goteborg, Sweden

Received 12 April 2011; Accepted 11 June 2011

Academic Editor: W. C. Hymer

Copyright © 2011 Anita Hokken-Koelega et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Anita Hokken-Koelega, Alexandra Keller, Viatcheslav Rakov, Stefan Kipper, and Jovanna Dahlgren, “Patient Acceptance, Ease of Use, and Preference for Norditropin NordiFlex with NordiFlex PenMate: Results from an Open-Label, User Survey of Everyday Use,” ISRN Endocrinology, vol. 2011, Article ID 803948, 8 pages, 2011. https://doi.org/10.5402/2011/803948.